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An increased chloride level in 
hypochloremia is associated with 
decreased mortality in patients 
with severe sepsis or septic shock
Hyung Jung Oh1,2, Seung Jun Kim3, Yong Chan Kim4,5, Eun Jin Kim4,5, In Young Jung4,5,  
Dong Hyun Oh4,5, Su Jin Jeong4,5, Nam Su Ku4,5, Sang Hoon Han4,5, Jun Yong Choi  4,5, 
 Young Goo Song4,5, Dong-Ryeol Ryu  2,6,7 & June Myung Kim4,5
Only a few observational studies investigated the association between hypochloremia and mortality 
in critically ill patients, and these studies included small number of septic patients. Also, no study has 
evaluated the effect of an increase in chloride (Cl−) concentration in hypochloremia on the mortality. A 
total of 843 Korean septic patients were divided into three groups based on their baseline Cl− level, and 
Cox analyses were performed to evaluate the 28-day mortality. Moreover, the change in Cl− level (ΔCl) 
from baseline to 24, 48, or 72 hour was determined, and Cox analyses were also conducted to evaluate 
the relationship of ΔCl with mortality. 301 (35.7%) patients were hypochloremic (Cl− < 97 mEq/L), and 
38 (4.5%) patients were hyperchloremic (Cl− > 110 mEq/L). During the follow-up period, 119 (14.1%) 
patients died. Hypochloremia was significantly associated with an increased mortality after adjusting 
for several variables, but an 1 mEq/L increase of ΔCl within 24 hour in patients with hypochloremia was 
significantly related to a decreased mortality. Caution might be required in severe septic patients with 
hypochloremia considering their increased mortality rate. However, an increased Cl− concentration 
might decrease the mortality rate of such patients.
Chloride is the most abundant anion in plasma and interstitial fluid, accounting for approximately one-third of 
plasma tonicity, and it affects acid‒base changes1,2. Although chloride is a major electrolyte measured routinely in 
daily practice, few studies have focused on chloride levels in critically ill patients3. Several studies have reported 
the incidence of chloride alterations and the association thereof with patient outcomes4–7.
Intravenous fluid resuscitation to restore the effective circulatory volume is a mainstay of early therapy 
for severely ill septic patients7,8. During the salvage phase of shock, 0.9% saline is typically infused into these 
patients9–11. However, because saline is rich in chloride12–14, these patients are susceptible to hyperchloremia 
during the post-resuscitation phase14,15. Moreover, hyperchloremic metabolic acidosis induced by use of 
chloride-rich solutions is associated with poor outcomes in critically ill patients5,14,16, particularly in those with 
severe sepsis and septic shock15. Thus, whether a chloride-liberal or chloride-restricted solution leads to better 
clinical outcomes in septic patients remains controversial17–19.
Hypochloremia is also independently associated with an increased risk of mortality in critically ill patients 
because of the occurrence of metabolic alkalosis20–22. However, only a few observational studies have evaluated 
the association between hypochloremia and hospital mortality, and they included only a small number of septic 
patients in the intensive care unit6,7. Accordingly, we stratified 843 Korean patients into hypochloremia, normo-
chloremia, and hyperchloremia groups based on their baseline chloride level and assessed the 28-day mortality 
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rate in the three groups. Furthermore, we investigated the effect of an increased chloride level on the 28-day 
mortality rate.
Results
Baseline characteristics. The mean age of the 843 patients was 65.8 ± 14.1 years, and 434 (51.5%) patients 
were male. The mean body mass index (BMI) was 23.1 ± 6.3 kg/m2, and the mean sequential organ failure assess-
ment (SOFA) score, and acute physiology and chronic health evaluation (APACHE) II score were 8.4 ± 3.0 and 
16.9 ± 6.7. The mean systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure 
(MAP) were 84.1 ± 24.3, 53.2 ± 13.3, and 63.5 ± 16.0 mmHg, respectively. Of the 843 patients, 294 (34.9%) had 
diabetes mellitus, 461 (54.7%) had hypertension, 70 (8.3%) had congestive heart failure, 136 (16.1%) had cer-
ebrovascular accidents, and 100 (11.9%) had a history of coronary arterial disease. Dementia, cancer, chronic 
pulmonary disease, chronic liver disease, and kidney disease were diagnosed in 5.2%, 33.9%, 14.0%, 10.6%, and 
17.0% of the patients, respectively (Table 1).
Three hundred and one (35.7%) patients were in the hypochloremic group, and 38 (4.5%) were in the hyper-
chloremic group. The patients in the hyperchloremic group had a significantly higher SOFA score (9.6 ± 3.1 
vs. 8.9 ± 3.0 in the hypochloremic group and 8.0 ± 2.9 in the normochloremic group, P < 0.001) and APACHE 
II score (20.4 ± 10.8 vs. 18.7 ± 5.9 in the hypochloremic group and 15.3 ± 7.1 in the normochloremic group, 
P = 0.003), serum blood urea nitrogen (BUN) level, sodium concentration, and chloride concentration compared 
with the other two groups. Moreover, there were more occurrence of acute kidney injury (AKI) in hypochloremic 
and hyperchloremic groups compared with normochloremic group, but there were no significant differences 
among the three groups in vasopressor needs and mechanical ventilation. White blood cell and platelet counts 
and serum lactate, C-reactive protein (CRP), and potassium levels were highest in the hypochloremic group. 
Serum albumin and total CO2 levels were significantly highest in the normochloremic group. We investigated 
“Net fluid accumulation for 72 hours” and calculated “Mean daily fluid balance”. Moreover, we examined the type 
and amount of fluid for 72 hours from the initial admission of emergency department (ED). Table 1 showed that 
mean daily fluid balance was 0.6 L and daily infused 0.9% saline was 1.5 L. However, there were no significant 
differences in mean daily fluid balance and daily infused 0.9% saline solution among the three groups (Table 1). 
In addition, although total infused fluid amount in hyperchloremic group for 48- and 72-hours were significantly 
increased compared with those in normochloremic group, there were no significant differences in 24-hour total 
infused fluid amount, 24-, 48-, and 72-hour infused 0.9% saline solution among the tree groups (Supplementary 
Tables 1 and 2).
Hypochloremia and 28-day mortality. One hundred and nineteen (14.1%) patients died during the 
follow-up period. The 28-day mortality rate was significantly higher in the hypochloremic group (59 patients, 
19.6%) and non-significantly higher in the hyperchloremic group (7 patients, 18.4%) compared with the nor-
mochloremic group (53 patients, 10.5%) (Table 1 and Fig. 1). In addition, Kaplan-Meier analysis showed that the 
cumulative survival rate was significantly lower in the hypochloremia and hyperchloremia groups compared with 
the normochloremia group (Fig. 2). Univariate Cox proportional regression analyses of 28-day mortality revealed 
that the hypochloremic group had a hazard ratio (HR) of 1.699 [95% confidence interval (CI), 1.129–2.557; 
P = 0.011] compared with the normochloremic group, while no significant association was evident in the hyper-
chloremic group (HR, 1.762; 95% CI 0.753–4.127; P = 0.192). Hypochloremia was also significantly associated 
with 28-day mortality after adjusting for age, sex, MAP, SOFA score, cerebrovascular accidents, serum BUN, albu-
min, and lactate compared with normochloremic patients (HR, 1.484; 95% CI, 1.078–2.339, P = 0.034) (Table 2).
The change of serum chloride concentration and 28-day mortality. The effect of an 1 mEq/L 
increase in the chloride concentration on the 28-day mortality rate was investigated next. The ΔCl24h, ΔCl48h, 
and ΔCl72h values were calculated and subjected to univariate Cox proportional regression analyses to determine 
their effects on 28-day mortality.
In the hypochloremic group, 28-day mortality was significantly decreased with each 1 mEq/L increase in 
the chloride concentration at 24 hour (HR, 0.914; 95% CI, 0.866–0.966; P = 0.001) and 48 hour (HR, 0.936; 95% 
CI, 0.888–0.987; P = 0.014), while there was no significant effect at 72 hour (HR, 0.961; 95% CI, 0.910–1.014; 
P = 0.258) (Table 3). In the normochloremic group, the 28-day mortality rate was significantly reduced by 12.1%, 
9.7%, and 10.5% for each 1 mEq/L increase in the chloride concentration at 24, 48, and 72 hour, respectively 
(Table 4). However, the ΔCl values were not significantly associated with the 28-day mortality rate at any of the 
time points in the hyperchloremic group (Table 5). Then, multivariate Cox analyses were performed, when the 
variables had a significant HRs such as ΔCl24h, ΔCl48h in hypochloremic group and ΔCl24h, ΔCl48h, and △Cl72h 
in normochloremic group. Tables 6 and 7 revealed that the 28-day mortality rate in the hypochloremic group was 
significantly decreased by 5.4% at 24 hour with an 1 mEq/L increase in the chloride level, after adjusting for age, 
sex, BMI, SBP, SOFA score, coronary arterial disease (CAD), serum albumin, and total CO2, whereas there was no 
significant effect of an 1 mEq/L increase in the chloride level on 28-day mortality at 48 hour (Table 6). In addition, 
in normochloremic group, increase of chloride level was not significantly associated with 28-day mortality in any 
time (Table 7).
Discussion
The 28-day mortality rate was significantly increased by 48.4% in the hypochloremic group compared with the 
normochloremic group, while it was not significantly increased in the hyperchloremic group compared with 
the normochloremic group. In contrast, in the hypochloremic group, the 28-day mortality rate was significantly 
decreased by 5.4% with an 1 mEq/L increases in ΔCl24h.
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Although the mechanism is unclear, hypochloremia is considered to be related to mortality in critically ill 
patients, possibly because of metabolic alkalosis20–22. However, the main factor responsible for mortality due to 
hypochloremia and metabolic alkalosis is unclear7,23. Although their study population was different from ours, 
Tani et al.7 reported that patients with metabolic acidosis had the highest mortality rate (metabolic acidosis, 
Variables
Total (n = 843, 
100%)
Hypochloremia 
(n = 301, 35.7%)
Normochloremia 
(n = 504, 59.8%)
Hyperchloremia 
(n = 38, 4.5%) p-value
Age, years 65.8 ± 14.1 64.4 ± 13.8 66.4 ± 14.1 69.7 ± 15.3 0.030
Male, n(%) 434 (51.5%) 162 (53.8%) 255 (50.6%) 17 (44.7%) 0.470
BMI, kg/m2 23.1 ± 6.3 22.9 ± 6.8 23.2 ± 6.0 23.0 ± 4.1 0.797
SBP, mmHg 84.1 ± 24.3 83.6 ± 24.9 84.7 ± 24.5 80.1 ± 13.8 0.485
DBP, mmHg 53.2 ± 13.3 53.5 ± 13.9 53.0 ± 13.2 53.5 ± 13.3 0.885
MAP, mmHg 63.5 ± 16.0 63.5 ± 16.7 63.6 ± 16.0 62.3 ± 10.5 0.902
SOFA score 8.4 ± 3.0 8.9 ± 3.0 8.0 ± 2.9 9.6 ± 3.1 <0.001
APACHE II score 16.9 ± 6.7 18.7 ± 5.9 15.3 ± 7.1 20.4 ± 10.8 0.003
Comorbidity disease, n(%)
DM 294 (34.9%) 114 (37.9%) 168 (33.3%) 12 (31.6%) 0.387
Hypertension 461 (54.7%) 159 (52.8%) 281 (55.8%) 21 (55.3%) 0.720
CHF 70 (8.3%) 34 (11.3%) 34 (6.7%) 2 (5.3%) 0.061
CVA 136 (16.1%) 42 (14.0%) 85 (16.9%) 9 (23.7%) 0.240
CAD 100 (11.9%) 34 (11.3%) 62 (12.3%) 4 (10.5%) 0.882
Dementia 44 (5.2%) 12 (4.0%) 27 (5.4%) 5 (13.2%) 0.056
Cancer 286 (33.9%) 103 (34.2%) 166 (32.9%) 17 (44.7%) 0.331
Chronic lung disease 118 (14.0%) 39 (13.0%) 74 (14.7%) 5 (13.2%) 0.783
Chronic liver disease 89 (10.6%) 32 (10.6%) 55 (10.9%) 2 (5.3%) 0.550
Chronic kidney disease 143 (17.0%) 51 (16.9%) 86 (17.1%) 6 (15.8%) 0.980
Acute kidney injury, n(%) 425 (50.4%) 176 (58.5%) 224 (44.4%) 25 (65.8%) 0.011
Vasopressor needs, n(%) 776 (92.1%) 276 (91.7%) 465 (92.3%) 35 (92.1%) 0.852
Mechanical ventilation, n(%) 208 (24.7%) 72 (23.9%) 125(24.8%) 11 (28.9%) 0.791
Mean daily fluid balance (L/d)† 0.6 ± 1.3 0.5 ± 1.5 0.4 ± 1.4 0.6 ± 1.7 0.304
Mean daily infused 0.9% saline, (L/d)†† 1.5 ± 0.7 1.5 ± 0.7 1.5 ± 0.7 1.4 ± 0.8 0.636
Laboratory values
WBC, × 103/mm3 13.8 ± 10.6 15.1 ± 11.1 13.2 ± 10.5 11.3 ± 6.4 0.013
Hb, g/dL 12.3 ± 7.2 12.5 ± 8.6 12.2 ± 6.4 11.6 ± 2.5 0.705
Platelet, × 103/mm3 199.5 ± 147.5 222.0 ± 202.6 186.6 ± 103.9 192.6 ± 95.8 0.004
BUN, mg/dL 34.7 ± 28.3 40.9 ± 36.0 29.7 ± 20.4 51.5 ± 34.5 <0.001
Creatinine, mg/dL 2.1 ± 2.0 2.7 ± 2.6 1.8 ± 1.3 2.7 ± 2.0 0.005
Albumin, g/dL 3.1 ± 0.7 3.0 ± 0.7 3.1 ± 0.7 2.9 ± 0.7 0.028
Total bilirubin, mg/dL 1.3 ± 1.6 1.4 ± 1.6 1.2 ± 1.4 1.3 ± 3.1 0.310
Lactate, mg/dL 4.2 ± 3.5 5.0 ± 4.1 3.7 ± 3.0 4.3 ± 2.9 <0.001
CRP, mg/L 146.6 ± 107.4 174.7 ± 109.9 131.0 ± 100.5 132.6 ± 131.0 <0.001
Sodium, mEq/L 135.1 ± 6.2 130.2 ± 5.4 137.3 ± 3.9 145.6 ± 7.3 <0.001
Potassium, mEq/L 4.2 ± 0.9 4.4 ± 1.0 4.1 ± 0.8 4.3 ± 1.0 <0.001
Chloride, mEq/L 99.4 ± 7.1 92.3 ± 5.0 102.5 ± 3.1 114.6 ± 3.6 <0.001
total CO2, mEq/L 17.7 ± 5.2 17.5 ± 6.1 18.2 ± 4.5 13.5 ± 4.0 <0.001
28-day mortality, n(%) 119 (14.1%) 59 (19.6%) 53 (10.5%) 7 (18.4%) 0.001
Table 1. Baseline characteristics at the time of ED admission among three groups (hypochloremia, 
normochloremia, and hyperchloremia)*. Data are expressed as mean (with standard deviation) or n (%). 
Abbreviations; ED, emergency department; BMI, body mass index; SBP, systolic blood pressure; DBP, 
diastolic blood pressure; MAP, mean arterial pressure; SOFA, sequential organ failure assessment; APACHE, 
acute physiology and chronic health evaluation; DM, diabetes mellitus; CHF, congestive heart failure; CVA, 
cerebrovascular accidents; CAD, coronary arterial disease; WBC, white blood cell; Hb, hemoglobin; BUN, 
blood urea nitrogen; CRP, C-reactive protein. *We investigated baseline demographic and laboratory data based 
on the time of patients’ ED admission, and stratified these data based on the hypochloremia, normochloremia, 
and hyperchloremia groups. Hypochloremia; chloride level less than 98 mEq/L at baseline. Normochloremia; 
chloride level between 98 to 110 mEq/L at baseline. Hyperchloremia; chloride level over 110 mEq/L at baseline. 
†To quantify 72-hour cumulative fluid balance, we used the following formula: [∑daily (fluid intake (L)−
total output (L)], which was defined as “net fluid accumulation for 72 hours”. “Mean daily fluid balance” was 
calculated as the arithmetic mean of the daily fluid balance from the admission of ED to 72 hours. ††According 
to our policy of the solution for severe sepsis, we usually use 0.9% saline.
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17.4%; metabolic alkalosis, 3.9%; normal, 6.27%; P = 0.027). Moreover, hypochloremic patients with metabolic 
acidosis had a higher mortality rate compared with those with metabolic alkalosis, suggesting that hypochloremia 
is associated with mortality independently of metabolic alkalosis.
Hypochloremia could be a sign of the severity of illness6 as a result of dysregulated homeostasis, including the 
serum chloride concentration. The SOFA score was significantly increased in the hypochloremic group compared 
with the normochloremic group in the current study. However, the hypochloremic group was independently 
associated with an increased 28-day mortality rate compared with the normochloremic group even after adjusting 
for the SOFA score. In addition, an increase in chloride level at 24 hour was significantly related to a decreased 
28-day mortality rate in the hypochloremic group.
Demonstrating that hypochloremia is a risk factor for mortality is problematic, because we did not show a 
causal link. Therefore, our results suggest an association between hypochloremia and a higher 28-day mortality 
rate in septic patients. The increase in the chloride concentration at 24 hour in the hypochloremic group was 
significantly associated with a decreased mortality rate.
In contrast, hyperchloremia was not significantly related to an increased 28-day mortality rate in this study. 
Unlike previous studies, the hyperchloremic group comprised only 38 (4.5%) patients, hampering identification 
of a significant association between hyperchloremia and an increased 28-day mortality rate. Thus, further studies 
involving larger populations are warranted to determine the relationship between hyperchloremia and mortality.
Intravenous fluid resuscitation is considered essential for early therapy in severe septic patients4,7,8, and 
chloride-rich solutions are typically used during the salvage phase of shock5,12–14. Such patients are susceptible 
Figure 1. Hypochloremia and 28-day mortality. The 28-day mortality rate was significantly higher in the 
hypochloremic group (59 patients, 19.6%) compared with the normochloremic group (53 patients, 10.5%), 
whereas there was no significant difference in 28-day mortality rate between hyperchloremic group and 
normochloremic group.
Figure 2. Kaplan-Meier curve for 28-day mortality. The cumulative survival rate wassignificantly lower in the 
hypochloremia and hyperchloremia groups compared with the normochloremia group (Log rank P = 0.009).
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to hyperchloremia during the post-resuscitation phase, and the consequent hyperchloremic metabolic acidosis 
leads to poor clinical outcomes in critically ill patients5,14–16. Therefore, several studies have investigated whether 
a chloride-liberal or chloride-restricted solution leads to better clinical outcomes in septic patients. Some stud-
ies reported a chloride-restricted solution to be superior18,19, while others suggested no significant difference in 
clinical outcomes17,24,25. To our knowledge, no study has evaluated the influence of an increased chloride con-
centration on mortality in hypochloremic septic patients. An increase in the chloride level from baseline during 
follow-up was associated with all-cause hospital mortality5 and the development of AKI4; however, these studies 
did not separate hypochloremic patients from normochloremic patients. Therefore, the analysis of the effect of 
elevated chloride levels on mortality in hypochloremic, normochloremic, and hyperchloremic patients was a 
strength of this study. Moreover, we report that an increased chloride level was independently associated with a 
decreased mortality rate in the hypochloremic group, suggesting that chloride-rich solutions could improve the 
clinical outcomes of hypochloremic patients.
This study had several limitations. First, this was a retrospective cohort study and thus was subject to selection 
bias. Second, the patients were arbitrarily classified into three groups according to our hospital reference, and the 
number of patients was distributed unevenly among the three groups. However, there are no established cut-off 
values for hypo-, normo-, or hyperchloremia5–7; most studies use cut-off values of 98 mEq/L for hypochloremia 
and 110 mEq/L for hyperchloremia5,6. Third, we did not investigate acid‒base changes according to alteration of 
the chloride level. Also, we analyzed only the change in chloride level within 72 hour; thus, our findings cannot be 
extrapolated beyond 72 hour. Despite these limitations, this study showed that hypochloremia is independently 
associated with an increased 28-day mortality rate, and that an increased chloride concentration is independently 
related to a decreased 28-day mortality rate in hypochloremic patients. In contrast a few previous studies pre-
sented hypochloremia is significantly associated with adverse clinical outcomes, they did not provide the effect of 
change of serum chloride concentration. Moreover, this study may be a cornerstone to prove the importance of 
chloride fluid replacement in the septic patients who have hypochloremia at baseline.
In conclusion, septic critically ill patients with hypochloremia at baseline should be monitored closely. 
Moreover, such patients may benefit from an increased chloride level. Therefore, a randomized-controlled inter-
ventional study involving a larger population is warranted to evaluate the association between an increased chlo-
ride level and the mortality rate of hypochloremic patients.
Univariate Multivariate
HR (95% CI) p-value HR (95% CI) p-value
Group
 Normochloremia Reference Reference
 Hypochloremia 1.699 (1.129–2.557) 0.011 1.484 (1.078–2.339) 0.034
 Hyperchloremia 1.762 (0.753–4.127) 0.192 1.354 (0.564–3.250) 0.497
Age (per 1year increase) 1.020 (1.003–1.037) 0.023 1.017 (0.997–1.038) 0.099
Male (vs. Female) 1.274 (0.840–1.932) 0.255 1.147 (0.744–1.768) 0.536
MAP (per 1 mmHg increase) 0.972 (0.956–0.988) 0.001 0.982 (0.966–0.998) 0.030
SOFA score (per 1unit increase) 1.220 (1.147–1.297) <0.001 1.124 (1.047–1.206) 0.001
CVA (vs. non-CVA) 1.797 (1.120–2.884) 0.015 1.883 (1.129–3.139) 0.015
BUN (per 1 mg/dL increase) 1.010 (1.008–1.013) <0.001 1.004 (1.001–1.008) 0.016
Albumin (per 1 g/dL increase) 0.369 (0.282–0.483) <0.001 0.411 (0.302–0.559) <0.001
Lactate (per 1 mg/dL increase) 1.163 (1.114–1.214) <0.001 1.115 (1.057–1.175) <0.001
Table 2. Univariate and multivariate Cox proportional hazards analyses for 28-day all-cause mortality. 
Abbreviations; HR, hazard ratio; CI, confidence interval; MAP, mean arterial pressure; SOFA, sequential organ 
failure assessment; CVA, cerebrovascular accidents; BUN, blood urea nitrogen.
Variables (n = 297) HR (95% CI) p-value
Delta chloride for 24 hours (ΔCl24h) 0.914 (0.866–0.966) 0.001
Delta chloride for 48 hours (ΔCl48h) 0.936 (0.888–0.987) 0.014
Delta chloride for 72 hours (ΔCl72h) 0.961 (0.910–1.014) 0.258
Table 3. Univariate Cox proportional hazards analyses for 28-day all-cause mortality per 1 mEq/L increase 
of chloride concentration in hypochloremic group. Abbreviations; HR, hazard ratio; CI, confidence interval. 
Definitions; The 24 hour delta chloride concentration (ΔCl24h) (mEq/L) was calculated by the following 
formula: [Cl24h] − [Clat baseline], where Cl24h is the chloride concentration at 24 hour, and Clat baseline is the baseline 
chloride concentration. The 48 hour delta chloride concentration (ΔCl48h) (mEq/L) was calculated by the 
following formula: [Cl48h] − [Clat baseline], where Cl48h is the chloride concentration at 48 hour, and Clat baseline is the 
baseline chloride concentration. The 72 hour delta chloride concentration (ΔCl72h) (mEq/L) was calculated by 
the following formula: [Cl72h] − [Clat baseline], where Cl72h is the chloride concentration at 72 hour, and Clat baseline is 
the baseline chloride concentration.
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Materials and Methods
Study population. A retrospective cohort study was conducted in Severance Hospital, a 2,400-bed tertiary 
teaching hospital at Yonsei University College of Medicine, South Korea. This study was approved by the institu-
tional review board (IRB) of the Yonsei University Health System Clinical Trial Center (4-2017-0078). The need 
for informed consent from patients was waived because of the retrospective design of the study. All clinical inves-
tigations were conducted in accordance with the guidelines of the 2013 Declaration of Helsinki.
Data were collected from patients admitted to the ED for severe sepsis or septic shock from January 2010 
to December 2015. The exclusion criteria were (a) age <18 years, (b) any contraindication for central venous 
catheterization, (c) pregnancy, (d) acute CVA e) acute coronary syndrome, (f) active gastrointestinal bleeding, 
(g) trauma, (h) drug overdose, (i) requirement for immediate surgery, (j) transfer to another institution, and (k) a 
do-not-resuscitate order. Severe sepsis and septic shock were defined according to standard criteria26. All patients 
were included in the study only once.
Data collection. Baseline characteristics, including demographic information and pre-existing chronic 
comorbidities, were collected at the time of admission to the ED. The SOFA27 and APACHE II28 scores were deter-
mined to assess disease severity based on the worst score obtained during the initial 24 hour of ED admission. In 
addition, the serum chloride concentration was measured by indirect potentiometry (ADVIA 1800 Chemistry 
System; Siemens Healthcare Diagnostic Inc., Oakville, ON, Canada). Chloride levels were determined at 24, 48, 
and 72 hour from baseline (time of admission to ED), and the change in chloride level relative to the baseline level 
was calculated for each time point.
Definitions. 
 (1) Hypochloremia was defined as a chloride concentration of <98 mEq/L at baseline. Normochloremia was 
defined as a chloride concentration of 98–110 mEq/L at baseline. Hyperchloremia was defined as a chlo-
ride concentration of >110 mEq/L at baseline.
 (2) The 24 hour delta chloride concentration (ΔCl24h) (mEq/L) was calculated by the following formula: 
[Cl24h] − [Clat baseline], where Cl24h is the chloride concentration at 24 hour, and Clat baseline is the baseline chlo-
ride concentration.
 (3) The 48 hour delta chloride concentration (ΔCl48h) (mEq/L) was calculated by the following formula: 
[Cl48h] − [Clat baseline], where Cl48h is the chloride concentration at 48 hour, and Clat baseline is the baseline chlo-
ride concentration.
 (4) The 72 hour delta chloride concentration (ΔCl72h) (mEq/L) was calculated by the following formula: 
[Cl72h] − [Clat baseline], where Cl72h is the chloride concentration at 72 hour, and Clat baseline is the baseline 
Variables (n = 498) HR (95% CI) p-value
Delta chloride for 24 hours (ΔCl24h) 0.879 (0.821–0.942) <0.001
Delta chloride for 48 hours (ΔCl48h) 0.903 (0.842–0.967) 0.004
Delta chloride for 72 hours (ΔCl72h) 0.895 (0.837–0.957) 0.001
Table 4. Univariate Cox proportional hazards analyses for 28-day all-cause mortality per 1 mEq/L increase of 
chloride concentration in normochloremic group. Abbreviations; HR, hazard ratio; CI, confidence interval. 
Definitions; The 24 hour delta chloride concentration (ΔCl24h) (mEq/L) was calculated by the following 
formula: [Cl24h] − [Clat baseline], where Cl24h is the chloride concentration at 24 hour, and Clat baseline is the baseline 
chloride concentration. The 48 hour delta chloride concentration (ΔCl48h) (mEq/L) was calculated by the 
following formula: [Cl48h] − [Clat baseline], where Cl48h is the chloride concentration at 48 hour, and Clat baseline is the 
baseline chloride concentration. The 72 hour delta chloride concentration (ΔCl72h) (mEq/L) was calculated by 
the following formula: [Cl72h] − [Clat baseline], where Cl72h is the chloride concentration at 72 hour, and Clat baseline is 
the baseline chloride concentration.
Variables (n = 48) HR (95% CI) p-value
Delta chloride for 24 hours (ΔCl24h) 1.089 (0.966–1.228) 0.161
Delta chloride for 48 hours (ΔCl48h) 0.983 (0.870–1.111) 0.787
Delta chloride for 72 hours (ΔCl72h) 0.920 (0.777–1.088) 0.330
Table 5. Univariate Cox proportional hazards analyses for 28-day all-cause mortality per 1 mEq/L increase 
of chloride concentration in hyperchloremic group. Abbreviations; HR, hazard ratio; CI, confidence interval. 
Definitions; The 24 hour delta chloride concentration (ΔCl24h) (mEq/L) was calculated by the following 
formula: [Cl24h] − [Clat baseline], where Cl24h is the chloride concentration at 24 hour, and Clat baseline is the baseline 
chloride concentration. The 48 hour delta chloride concentration (ΔCl48h) (mEq/L) was calculated by the 
following formula: [Cl48h] − [Clat baseline], where Cl48h is the chloride concentration at 48 hour, and Clat baseline is the 
baseline chloride concentration. The 72 hour delta chloride concentration (ΔCl72h) (mEq/L) was calculated by 
the following formula: [Cl72h] − [Clat baseline], where Cl72h is the chloride concentration at 72 hour, and Clat baseline is 
the baseline chloride concentration.
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chloride concentration.
 (5) AKI is defined as any of the followings; Increase in serum creatinine by ≥0.3 mg/dL within 48 hours or 
increase in serum creatinine to ≥1.5 times baseline, which is known or presumed to have occurred within 
the prior 7 days or urine volume <0.5 mL/kg/h for 6 hours29.
 (6) Net fluid accumulation was measured by the formula: [∑daily (fluid intake (L) − total output (L)]30.
 (7) Mean daily fluid balance was also calculated as the arithmetic mean of the daily fluid balance from the 
admission of ED to 72 hours31.
 (8) According to our policy of the solution for severe sepsis, we usually use 0.9% saline.
Study outcomes. The observation period ended 28 days after ED admission, and the primary outcome was 
the 28-day all-cause mortality rate.
Statistical analysis. Statistical analysis was performed using SPSS for Windows, version 22.0 (SPSS Inc., 
Chicago, IL, USA). The patients were classified into hypochloremia, normochloremia, and hyperchloremia 
groups based on their baseline chloride levels. Continuous variables are presented as means ± standard deviation 
and categorical variables as numbers and percentages. The baseline characteristics of the groups were compared 
by analysis of variance for continuous variables and the χ2 test for categorical variables.
Kaplan-Meier survival curves were assessed using the log-rank test to compare the differences in 28-day mor-
tality among groups. A Cox model was fit to evaluate the influence of the chloride level on 28-day mortality 
and the effect of an increased chloride level at 24, 48, or 72 hour from baseline on 28-day mortality. First, we 
selected variables using the threshold of P-value < 0.2 from univariate analysis (Supplementary Table 3), and 
then confirmed new variables for adjustment of multivariate Cox analysis after assessing colinearity between 
the selected variables. Finally, MAP, SOFA score, CVA, serum BUN, albumin, and lactate were chosen to adjust 
for multivariate Cox analysis including age and sex to evaluate the effect of hypochloremia or hyperchloremia 
on 28-day mortality. With the same way, we performed multivariate Cox analyses for the effects of increase of 
chloride level on the mortality; BMI, SBP, SOFA score, CAD, serum albumin and total CO2 were selected for 
Variables (n = 297)
Multivariate
24 hours 48 hours
HR (95% CI) p-value HR (95% CI) p-value
Delta chloride (per 1 mEq/L increase of chloride level) 0.946 (0.888–0.997) 0.023 0.961 (0.907–1.018) 0.174
Age (per 1year increase) 1.033 (0.998–1.069) 0.065 1.039 (1.002–1.078) 0.041
Male (vs. Female) 1.082 (0.542–2.160) 0.823 1.103 (0.530–2.297) 0.793
BMI (per 1 kg/m2 increase) 1.028 (1.003–1.054) 0.028 1.034 (1.007–1.060) 0.012
SBP (per 1 mmHg increase) 0.987 (0.971–1.003) 0.107 0.994 (0.978–1.009) 0.435
SOFA score (per 1unit increase) 1.129 (1.014–1.257) 0.026 1.113 (0.992–1.248) 0.067
CAD (vs. non-CAD) 2.165 (0.959–4.891) 0.063 2.279 (0.990–5.248) 0.053
Albumin (per 1 g/dL increase) 0.427 (0.261–0.699) 0.001 0.376 (0.227–0.622) <0.001
Total CO2 (per 1mEq/L increase) 0.925 (0.871–0.982) 0.011 0.912 (0.855–0.972) 0.004
Table 6. Multivariate Cox proportional hazards analyses for 28-day all-cause mortality per increase of chloride 
concentration for 24 & 48 hours in hypochloremic group. Abbreviations; HR, hazard ratio; CI, confidence 
interval; BMI, body mass index; SBP, systolic blood pressure; SOFA, sequential organ failure assessment; CAD, 
coronary arterial disease.
Variables (n = 297)
Multivariate
24 hours 48 hours 72 hours
HR (95% CI)
Variables 
(n = 297) HR (95% CI)
Variables 
(n = 297) HR (95% CI)
Variables 
(n = 297)
Delta chloride (per 1 mEq/L increase of 
chloride level) 0.930 (0.853–1.014) 0.098 0.986 (0.907–1.072) 0.747 0.975 (0.896–1.062) 0.562
Age (per 1year increase) 1.008 (0.979–1.037) 0.604 1.009 (0.977–1.042) 0.576 1.004 (0.972–1.038) 0.792
Male (vs. Female) 1.372 (0.711–2.648) 0.345 1.485 (0.704–3.133) 0.300 1.848 (0.827–4.127) 0.134
SOFA score (per 1unit increase) 1.117 (1.000–1.248) 0.050 1.134 (1.005–1.279) 0.042 1.124 (0.992–1.274) 0.066
BUN (per 1 mg/dL increase) 1.013 (1.003–1.023) 0.008 1.013 (1.001–1.024) 0.028 1.014 (1.002–1.026) 0.027
Albumin (per 1 g/dL increase) 0.527 (0.328–0.845) 0.008 0.334 (0.201–0.556) <0.001 0.339 (0.200–0.573) <0.001
Total CO2 (per 1mEq/L increase) 0.996 (0.918–1.080) 0.915 1.024 (0.933–1.123) 0.620 1.027 (0.934–1.130) 0.579
Table 7. Multivariate Cox proportional hazards analyses for 28-day all-cause mortality per increase of chloride 
concentration for 24, 48 & 72 hours in normochloremic group. Abbreviations; HR, hazard ratio; CI, confidence 
interval; SOFA, sequential organ failure assessment; BUN, blood urea nitrogen.
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adjustment including age and sex in hypochloremic group (Table 6), and SOFA score, serum BUN, albumin, and 
total CO2 were adjusted for multivariate Cox analysis including age and sex in normochloremic group (Table 7). 
The results are presented as hazard ratios (HRs) with 95% confidence intervals (CIs). To confirm the assumption 
of proportionality, a time-dependent covariate analysis was performed, the results of which were not statistically 
significant, suggesting that the proportional hazards assumption was reasonable. All tests were two-sided, and a 
P value of <0.05 was considered to indicate statistical significance.
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